| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_409977e6c492532c2536cfd27e2f19bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfc234209533aef076889c786cd4f6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_295309dfb77ee3597f220dd5df49fbba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e4cd1ec3ba0b0d3c24542ab0995e7f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_574e34a1bb78372941e570642ea8ed9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdf9c14d103fdd3054359be80292e0a1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2008-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9fba98b8c1d9507994ab23630d4aca3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7553418f1ec2a8fd291810317b050c55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faceec9a5b27b77ca75a9a2092c3da84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bdc2007eafeba109910e257b4979913
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cffac2638a3b02a25346f47edd3e510 |
| publicationDate |
2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
IL-192180-A |
| titleOfInvention |
Use of 1c inhibitors with a reduced level of terminal residues of cialic acid for the manufacture of medical preparations for the prevention, reduction or treatment of injuries related to ischemia and / or perfusion |
| abstract |
The present invention relates to the therapeutic and prophylactic use of Cl inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The Cl inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke. |
| priorityDate |
2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |